Superba(TM) Krill Oil Receives Regulatory Approval in India

New Delhi, September 10, 2014 – Aker BioMarine Antarctic AS, a customer-driven supplier of krill-derived phospholipid omega-3 products, has received product approval for Superba(TM) Krill oil from Food Safety Standards Authorities of India (FSSAI). According to publically available information, Superba(TM) Krill oil is, as of today, the first and only krill oil that has obtained product approval by the FSSAI.

“We are delighted to introduce Superba(TM) Krill oil – an omega-3 product evaluated in several clinical studies – to the Indian market,” said Atul Barman, Aker BioMarine Antarctic AS’s India representative in Mumbai. “This new ingredient approval will enable Indian consumers to benefit from omega-3 fatty acids in phospholipid form. Omega-3 phospholipids are more efficiently incorporated into cell membranes and are therefore an excellent source of omega-3 fatty acids to support heart, brain and joint health.”

“This approval represents a key milestone for our entry into India,” said Tim de Haas, Vice President of Business Development, Aker BioMarine Antarctic AS, Oslo, Norway. “We feel confident that with our local presence we can successfully support our customers in India. Backed by our success, especially in the US and Australian markets, expanding into the Indian dietary supplement market presents great opportunities for Superba(TM) Krill oil.” CCI Newswire